Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Scientists discover a potential new marker to personalised therapy for breast cancer
A new study from the University of Southampton, UK, has discovered that ‘crown-like structures’ surrounding breast…
Study tests link between common blood pressure pills and breast cancer
Curtin University researchers will examine if the long-term use of a popular blood pressure medication increased…
Perception-based nanosensor platform could advance detection of ovarian cancer
Ovarian cancer kills 14,000 women in the United States every year. It’s the fifth leading…
Fishing for new leads in a rare melanoma
Zebrafish are an emerging power tool in cancer research. They can be engineered to light up when certain genes turn…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.